Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Breast Cancer Research : Bcr
Tinholt, Mari M; Vollan, Hans Kristian Moen HK; Sahlberg, Kristine Kleivi KK; Jernström, Sandra S; Kaveh, Fatemeh F; Lingjærde, Ole Christian OC; Kåresen, Rolf R; Sauer, Torill T; Kristensen, Vessela V; Børresen-Dale, Anne-Lise AL; Sandset, Per Morten PM; Iversen, Nina N